Skip to main content
OpenTrials
Completed

NCT Number: NCT04845906

A 7 Day Adhesive Device Wear Study to Evaluate BD StatLock™ Devices

This study is a prospective healthy human volunteer wear study to evaluate the safety and performance of the StatLock™ Catheter Stabilization Device and the StatLock™ stabilization device Accessory (Foam Strip) and to meet the design input requirements.

Completed

Looking for future studies?

Notify Me

Key information

Age range

14 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

TKL Research, Inc, Fair Lawn, New Jersey, United States

Loading trial locations.

About this study

This is a healthy human wear study of a minimum of 100 study participants who will wear the StatLock™ Catheter Stabilization Device and the StatLock™ stabilization device accessory (Foam Strip). Participants will report to the research center, on Day 0 to have their skin assessed by the investigator, clinician, and/or designee. On Day 0 the participants will have the StatLock™ Catheter Stabilization Devices and the foam strip applied. There will be 4 separate StatLock™ devices being tested, which will be randomly applied to the participants on their inner (ventral) forearms. Each participant will have 2 separate devices applied, one to each arm. Those participants who have the StatLock ™ Arterial Plus, StatLock™ Dialysis II, or the StatLock IV Select , will also have the Foam Strip applied.

The participant will also wear a dressing over top of a StatLock™ compatible catheter, which will be connected to an extension set. For this study, the catheter will not be inserted into the study participant but instead will be shortened or modified and placed on the skin and secured with the StatLock™ Stabilization Device. The catheter tip will be marked with indelible ink, to assess for any catheter movement. The use of the catheters, extension set, and the dressing represents how the device would be used in a clinical setting.

Once the devices are applied the participant will have the skin assessed (using a modified Draize Scale) by the investigator, clinician, and/or designee on Day 0. The participant will wear the devices at home for 1 week and will return on Day 7 for a skin assessment, evaluation of pad and foam strip lift, and catheter movement, evaluation of pain, and removal of the devices by the investigator, clinician, and/or designee. On Day 8, there may be a phone call and/or video call with the participant to review the skin condition of the site where the device was removed from.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Any healthy human, 14 years of age or older, regardless of gender (Note: Consent of guardian or parent may be required for patients who are under 18 years of age).
  • If they provide written and informed consent.
  • Expected to be available for observation from consent, to the application on Day 0, and then removal of the StatLock™ Catheter Stabilization Device on Day 7, and for a follow up phone and/or video call on Day 8 for a skin assessment.
  • Participant agrees to maintain a diary from device application, Day 0, through device removal, Day 7.
  • Agree to keep the StatLock™ Catheter Stabilization Device, ancillary products, and site dry throughout the study
  • Agrees to not use moisturizers, lotions, or any product labeled moisturizing for the duration of the study, at or around the site where the devices will be applied (inner (ventral) forearm).

Exclusion criteria

  • If their skin was burned or scarred at the insertion site, or has any other skin condition which may affect the adherence and/or interpretation of the study results.
  • If they have a known allergy to the study products (known tape or adhesive allergy).
  • Has a medical condition which may prevent him or her from completing the study or place the study participant at undue risk.

Treatment and study plan

StatLock™ Catheter Stabilization Device and the StatLock™ stabilization device accessory (Foam Strip)

Device

Each participant will have 2 separate devices applied, one to each arm, with or without a Foam Strip.The participant will also wear a dressing over top of a StatLock™ compatible catheter, which will be connected to an extension set. For this study, the catheter will not be inserted into the study participant but instead will be shortened or modified and placed on the skin and secured with the StatLock™ Stabilization Device. The use of the catheters, extension set, and the dressing represents how the device would be used in a clinical setting.

Other names: StatLock™ Pro- SLP001, StatLock™ IV Select- IV0521CE, StatLock™ Arterial Plus- ART0222CE, StatLock™ Dialysis II- VDS2, Foam Strip- SL0100 (StatLock™ Stabilization Device Accessory)

Primary outcomes

  1. Percent lift of the StatLock™ Catheter Stabilization Device Pad at Day 7

    Time frame: Day 7

    Device pad lift will be assessed using a Visual Analog Scale, ranging from 0 - Fully adhered to 100 - Device absent. When the percent lift at day 7 is >50%, it is considered a failure.

  2. Percent of Device Movement of the StatLock™ Catheter Stabilization Device at Day 7

    Time frame: Day 7

    The percent of device movement of the catheter will be assessed using a Visual Analog Scale from 0 (no movement) to 100 (completely displaced).

  3. Ease of Removal of the StatLock™ Catheter Stabilization Device

    Time frame: Day 7

    Ease of removal will be assessed using a 100 mm Visual Analog Scale where 0 is very easy to remove and 100 is very difficult to remove.

  4. Percent of participants with erythema score ≥ 2

    Time frame: Day 7

    Erythema score will be assessed using a modified Draize scale with scores ranging from 0 to 3, as follows: 0 - no visible reaction; 0.5 - Doubtful or negligible erythema reaction; 1.0 - mild or just perceptible macular erythema reaction in a speckled/follicular, patchy or confluent pattern (slight pinking); 2.0 - Moderate erythema reaction in a confluent pattern (definite redness); 3 - Strong or brisk erythema reaction that may spread beyond the test site).

Secondary outcomes

  1. Percent lift of the Foam Strip (StatLock™ Stabilization Device Accessory) at Day 7

    Time frame: Day 7

    The percent lift of the foam strip will be assessed using a Visual Analog Scale ranging from 0 (fully adhered) to 100 (device accessory absent).

  2. Ease of Removal of the StatLock™ Stabilization Device Foam Strip

    Time frame: Day 7

    The ease of removal will be assessed using a 100 mm Visual Analog Scale where 0 is very easy to remove and 100 is very difficult to remove.

  3. Level of pain upon removal of the StatLock™ Catheter Stabilization Device

    Time frame: Day 7

    Pain upon removal of the device will be assessed using a 100 mm Visual Analog Scale where 0 is no pain and 100 is unbearable pain.

Other outcomes

  1. Rate of StatLock™ Catheter Stabilization device-related adverse events

    Time frame: Day 0 to Day 8

    Rate of device-related adverse events.

Sponsors and collaborators

Lead sponsor

Becton, Dickinson and Company

Industry

Registry information

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Apr 15, 2021
Registry last updated
Sep 8, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.